同源康医药-B(02410)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02410 同源康医药-B

已收盘 12-23 16:08:41

54.500

-0.200

-0.37%

最高56.550	最低53.300	成交量33.55万
今开54.700	昨收54.700	日振幅5.94%
总市值202.11亿	流通市值105.19亿	总股本3.71亿
成交额1,829万	换手率0.17%	流通股本1.93亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02410","market":"HK","secType":"STK","nameCN":"同源康医药-B","latestPrice":54.5,"timestamp":1734941321014,"preClose":54.7,"halted":0,"volume":335500,"delay":0,"floatShares":193000000,"shares":370835818,"eps":-1.4085453,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.2,"latestTime":"12-23 16:08:41","open":54.7,"high":56.55,"low":53.3,"amount":18293575,"amplitude":0.059415,"askPrice":56,"askSize":500,"bidPrice":54.5,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-1.4925360223776225,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735003800000},"adr":0,"listingDate":1724083200000,"adjPreClose":54.7,"openAndCloseTimeList":[[1734917400000,1734926400000],[1734930000000,1734940800000]],"volumeRatio":1.51529,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02410/wiki","defaultTab":"wiki","newsList":[{"id":"1113712071","title":"异动解读 | 同源康医药-B获H股全流通批准 盘中股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113712071","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113712071?lang=zh_cn&edition=full","pubTime":"2024-12-20 13:48","pubTimestamp":1734673706,"startTime":"0","endTime":"0","summary":"同源康医药-B(02410)今日盘中股价大涨5.24%,引起广泛关注。\n\n消息面上,该公司获得中国证监会批准,将其持有的1.73亿股非上市股份转换为H股在港交所主板上市流通。这一举措提高了该股的流动性,为其股价上涨奠定了基础。\n\n同源康医药-B获批H股全流通,反映了监管层对该公司的良性运营前景予以认可。通过增加可流通股份,将吸引更多资金进入,提振公司发展。在利好政策催化下,同源康医药-B今日盘中大涨5.24%,表现亮眼。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 同源康医药-B获H股全流通批准 盘中股价大涨5.24%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02410"],"gpt_icon":0},{"id":"2492643273","title":"同源康医药(02410.HK)获中证监H股全流通备案通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2492643273","media":"阿斯达克财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492643273?lang=zh_cn&edition=full","pubTime":"2024-12-20 08:57","pubTimestamp":1734656220,"startTime":"0","endTime":"0","summary":"同源康医药-B(02410.HK) 公布，中国证监会本月18日已就H股全流通向该公司发出备案通知书。据悉，有关该公司25名股东持有1.73亿股非上市股份转换为H股的H股全流通中国证监会备案已告完成。于完成有关转换及联交所授予上市批准后，该等1.73亿股H股将于联交所主板上市及买卖。备案通知书将自中国证监会核准之日起12个月内有效。截至昨日(19日)，H股全流通的实施计划详情尚未最终确定。(js/w)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240819111845079_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240819111845079_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1405440/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["159938","02410","09939","BK1161","BK1515","BK1574"],"gpt_icon":0},{"id":"2492317488","title":"同源康医药-B(02410)：中国证监会发出关于公司申请H股全流通的备案通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2492317488","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492317488?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:52","pubTimestamp":1734619976,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B(02410)发布公告，于2024年12月18日，中国证监会已就H股全流通向公司发出备案通知书。根据备案通知书，有关公司25名股东持有约1.74亿股非上市股份转换为约1.74亿股H股的H股全流通的中国证监会备案已告完成。于完成有关转换及联交所授予上市批准后，该等约1.74亿股H股将于联交所主板上市及买卖。备案通知书将自中国证监会核准之日(即2024年12月18日)起12个月内有效。于本公告日期，H股全流通的实施计划详情尚未最终确定。公司将根据上市规则项下的规定及╱或内幕消息条文适时就H股全流通的进展作出进一步公告。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227363.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","09939","BK1574","BK1161","02410","159938"],"gpt_icon":0},{"id":"2492112663","title":"港股异动 | 同源康医药-B(02410)涨超7%创新高 海外重磅ADC获突破性疗法认定 公司核心产品正进行临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2492112663","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492112663?lang=zh_cn&edition=full","pubTime":"2024-12-19 15:03","pubTimestamp":1734591834,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药-B午后涨超7%创上市新高，盘中高见50.5港元，较招股价12.1港元已涨超300%。截至发稿，涨6.28%，报49.95港元，成交额1174.21万港元。海通证券指出，Dato-DXd获首个突破性疗法认定，为EGFR突变NSCLC患者带来新希望。招股书显示，同源康医药公司已建立由11款候选药物组成的管线，包括2个低风险产品TY-9591、TY-302，5款创新临床产品，4款处于临床前阶段的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226969.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03347","ADC","BK4080","BK1141","BK1574","BK4231","09939","BK1515","02410","BK1583","BK1576","BK1161","159938"],"gpt_icon":0},{"id":"2492297620","title":"同源康医药-B盘中异动 临近收盘急速上涨6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492297620","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492297620?lang=zh_cn&edition=full","pubTime":"2024-12-18 15:58","pubTimestamp":1734508691,"startTime":"0","endTime":"0","summary":"2024年12月18日临近收盘15时58分，同源康医药-B股票出现波动，股价大幅拉升6.12%。截至发稿，该股报45.950港元/股，成交量16.45万股，换手率0.09%，振幅9.47%。同源康医药-B股票所在的生物技术行业中，整体涨幅为0.37%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。TY-2136b为自主研发、口服ROS1/NTRK抑制剂,用于治疗实体瘤。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218155811ab813b36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218155811ab813b36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","09939","BK1515","02410"],"gpt_icon":0},{"id":"2491739161","title":"同源康医药-B盘中异动 早盘股价大跌7.89%报41.450港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491739161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491739161?lang=zh_cn&edition=full","pubTime":"2024-12-13 10:51","pubTimestamp":1734058265,"startTime":"0","endTime":"0","summary":"2024年12月13日早盘10时51分，同源康医药-B股票出现波动，股价快速跳水7.89%。截至发稿，该股报41.450港元/股，成交量3.45万股，换手率0.02%，振幅8.11%。资金方面，该股资金流入58.63万港元，流出70.905万港元。同源康医药-B股票所在的生物技术行业中，整体跌幅为0.70%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213105105ab74135c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213105105ab74135c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","02410","09939","BK1161","BK1574"],"gpt_icon":0},{"id":"2490930032","title":"同源康医药-B盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490930032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490930032?lang=zh_cn&edition=full","pubTime":"2024-12-10 10:06","pubTimestamp":1733796386,"startTime":"0","endTime":"0","summary":"2024年12月10日早盘10时06分，同源康医药-B股票出现异动，股价快速下挫5.17%。截至发稿，该股报42.200港元/股，成交量2.4万股，换手率0.01%，振幅7.30%。同源康医药-B股票所在的生物技术行业中，整体跌幅为0.53%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210100626ab6b6a9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210100626ab6b6a9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09939","02410","BK1515","BK1161"],"gpt_icon":0},{"id":"2488135975","title":"同源康医药-B盘中异动 急速拉升5.67%报41.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488135975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488135975?lang=zh_cn&edition=full","pubTime":"2024-12-04 13:17","pubTimestamp":1733289465,"startTime":"0","endTime":"0","summary":"2024年12月04日下午盘13时17分，同源康医药-B股票出现异动，股价大幅拉升5.67%。截至发稿，该股报41.000港元/股，成交量7500股，换手率0.00%，振幅2.84%。资金方面，该股资金流入14.2万港元，流出0港元。同源康医药-B股票所在的生物技术行业中，整体跌幅为0.83%。其相关个股中，晶泰科技、同源康医药-B、华康生物医学涨幅较大，振幅较大的相关个股有晶泰科技、来凯医药-B、云顶新耀-B，振幅分别为17.71%、10.29%、8.77%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204131745abf4a1c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204131745abf4a1c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","02410","BK1161","BK1574","09939"],"gpt_icon":0},{"id":"2488939442","title":"同源康医药-B盘中异动 早盘急速上涨6.24%报39.150港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488939442","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488939442?lang=zh_cn&edition=full","pubTime":"2024-12-03 09:51","pubTimestamp":1733190696,"startTime":"0","endTime":"0","summary":"2024年12月03日早盘09时51分，同源康医药-B股票出现波动，股价大幅上涨6.24%。截至发稿，该股报39.150港元/股，成交量1.1万股，换手率0.01%，振幅6.24%。资金方面，该股资金流入40.0675万港元，流出0港元。同源康医药-B股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，云顶新耀-B、同源康医药-B、再鼎医药涨幅较大，振幅较大的相关个股有帝王国际投资、云顶新耀-B、华康生物医学，振幅分别为11.32%、10.84%、10.64%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203095136abf1545f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203095136abf1545f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1515","BK1574","BK1161","09939"],"gpt_icon":0},{"id":"2486502801","title":"迈博药业-B盘中异动 下午盘急速下挫9.33%报0.340港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486502801","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486502801?lang=zh_cn&edition=full","pubTime":"2024-11-26 15:16","pubTimestamp":1732605366,"startTime":"0","endTime":"0","summary":"2024年11月26日下午盘15时16分，迈博药业-B股票出现波动，股价急速下挫9.33%。截至发稿，该股报0.340港元/股，成交量4万股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出1.36万港元。迈博药业-B股票所在的生物技术行业中，整体涨幅为0.07%。迈博药业-B公司简介：迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126151606abdfd944&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126151606abdfd944&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02257","02410","02181"],"gpt_icon":0},{"id":"2486336041","title":"港股异动 | 同源康医药-B(02410)午后涨近20%再创新高 核心产品TY-959已获得IND批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2486336041","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486336041?lang=zh_cn&edition=full","pubTime":"2024-11-26 14:57","pubTimestamp":1732604248,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药-B午后涨近20%，高见38.5港元，创上市新高，较招股价12.1港元已涨超2倍。截至发稿，涨11.52%，报34.85港元，成交额1189.25万港元。据悉，公司已建立由11款候选药物组成的管线，包括2个低风险产品TY-9591、TY-302，5款创新临床产品，4款处于临床前阶段的产品。值得注意的是，公司已获得国家药监局对其核心产品TY-9591的II期和III期临床试验的IND批准，同时正在进行产品TY-302和TY-2136b的关键临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1215901.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02410","BK1515","TY","159938","09939","BK1161","BK1574"],"gpt_icon":0},{"id":"2486046151","title":"同源康医药-B盘中异动 股价大涨5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486046151","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486046151?lang=zh_cn&edition=full","pubTime":"2024-11-26 14:19","pubTimestamp":1732601992,"startTime":"0","endTime":"0","summary":"2024年11月26日下午盘14时19分，同源康医药-B股票出现异动，股价急速拉升5.60%。截至发稿，该股报33.000港元/股，成交量27.1万股，换手率0.14%，振幅5.60%。同源康医药-B股票所在的生物技术行业中，整体跌幅为0.25%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126141952abdfbd3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126141952abdfbd3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","09939","BK1161","BK1574","BK1515"],"gpt_icon":0},{"id":"2486045983","title":"同源康医药－Ｂ(02410)股价上升5.44%，现价港币$32.95","url":"https://stock-news.laohu8.com/highlight/detail?id=2486045983","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486045983?lang=zh_cn&edition=full","pubTime":"2024-11-26 14:19","pubTimestamp":1732601940,"startTime":"0","endTime":"0","summary":"[上升股]同源康医药－Ｂ(02410) 股价在下午02:19比前收市价上升5.44%，现股价为港币$32.95。至目前为止，今日最高价为$32.95，而最低价为$31.25。总成交量为1.8万股，总成交金额为港币$58.195万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2411261469/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09939","02410","BK1515","BK1161","159938","BK1574"],"gpt_icon":0},{"id":"1101367621","title":"异动解读 | 同源康医药-B盘中大涨7.91% 市场关注公司产品潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=1101367621","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101367621?lang=zh_cn&edition=full","pubTime":"2024-11-22 16:22","pubTimestamp":1732263758,"startTime":"0","endTime":"0","summary":"同源康医药-B(02410.HK)今日盘中大涨7.91%,引发市场关注。\n\n消息面上,公司是一家致力于开发及商业化医药产品的中国公司,其主要产品包括TY-9591、TY-302和TY-2136等。TY-9591是一种第三代EGFR-TKI,对EGFR突变具有抗肿瘤作用;TY-302是一种为治疗乳腺癌及前列腺癌等晚期实体瘤而开发的强效、选择性口服CDK4/6抑制剂;TY-2136b为自主研发、口服ROS1/NTRK抑制剂,用于治疗实体瘤。\n\n投资者看好同源康医药-B在肿瘤治疗领域的较强产品管线,对公司未来发展前景持乐观预期,推动股价在盘中大涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 同源康医药-B盘中大涨7.91% 市场关注公司产品潜力","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02410"],"gpt_icon":0},{"id":"2485280488","title":"同源康医药-B盘中异动 股价大涨5.40%报29.300港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485280488","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485280488?lang=zh_cn&edition=full","pubTime":"2024-11-22 15:59","pubTimestamp":1732262379,"startTime":"0","endTime":"0","summary":"2024年11月22日临近收盘15时59分，同源康医药-B股票出现波动，股价快速上涨5.40%。截至发稿，该股报29.300港元/股，成交量1.25万股，换手率0.01%，振幅4.68%。资金方面，该股资金流入25.945万港元，流出5.6675万港元。同源康医药-B股票所在的生物技术行业中，整体跌幅为1.81%。其相关个股中，迈博药业-B、嘉和生物-B、云康集团涨幅较大，振幅较大的相关个股有华领医药-B、晶泰科技、北海康成-B，振幅分别为16.67%、15.10%、14.20%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112215593998e44206&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112215593998e44206&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","02410","BK1161","BK1574","09939"],"gpt_icon":0},{"id":"2485238063","title":"同源康医药－Ｂ(02410)股价上升5.396%，现价港币$29.3","url":"https://stock-news.laohu8.com/highlight/detail?id=2485238063","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485238063?lang=zh_cn&edition=full","pubTime":"2024-11-22 15:59","pubTimestamp":1732262340,"startTime":"0","endTime":"0","summary":"[上升股]同源康医药－Ｂ(02410) 股价在下午03:59比前收市价上升5.396%，现股价为港币$29.3。至目前为止，今日最高价为$29.3，而最低价为$28.0。总成交量为1.25万股，总成交金额为港币$35.872万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2411223094/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1515","BK1161","BK1574","02410","09939","159938"],"gpt_icon":0},{"id":"2484302168","title":"同源康医药－Ｂ(02410)股价上升5.104%，现价港币$27.8","url":"https://stock-news.laohu8.com/highlight/detail?id=2484302168","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484302168?lang=zh_cn&edition=full","pubTime":"2024-11-20 15:29","pubTimestamp":1732087740,"startTime":"0","endTime":"0","summary":"[上升股]同源康医药－Ｂ(02410) 股价在下午03:29比前收市价上升5.104%，现股价为港币$27.8。至目前为止，今日最高价为$27.8，而最低价为$25.5。总成交量为25.8万股，总成交金额为港币$699.858万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2411201047/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["159938","09939","BK1515","BK1161","BK1574","02410"],"gpt_icon":0},{"id":"2484299527","title":"同源康医药-B盘中异动 临近收盘快速上涨5.05%报26.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484299527","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484299527?lang=zh_cn&edition=full","pubTime":"2024-11-19 15:52","pubTimestamp":1732002775,"startTime":"0","endTime":"0","summary":"2024年11月19日临近收盘15时52分，同源康医药-B股票出现异动，股价大幅上涨5.05%。截至发稿，该股报26.000港元/股，成交量14.9万股，换手率0.08%，振幅9.49%。资金方面，该股资金流入284.358万港元，流出39.9万港元。同源康医药-B股票所在的生物技术行业中，整体涨幅为0.37%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119155255a24515d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119155255a24515d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1574","09939","BK1161","BK1515"],"gpt_icon":0},{"id":"2484247617","title":"同源康医药－Ｂ(02410)股价显著波动14.493%，现价港币$26.0","url":"https://stock-news.laohu8.com/highlight/detail?id=2484247617","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484247617?lang=zh_cn&edition=full","pubTime":"2024-11-18 15:59","pubTimestamp":1731916740,"startTime":"0","endTime":"0","summary":"[异动股]同源康医药－Ｂ(02410) 股价在下午03:59出现显著波动14.493%，现股价为港币$26.0，比前收市价上升7.66%5.59%。至目前为止，今日最高价为$26.0，而最低价为$22.5。总成交量为7.7万股，总成交金额为港币$183.712万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205154958317_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205154958317_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAC241118109/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02410","BK1515","BK1574","159938","09939"],"gpt_icon":0},{"id":"2484172446","title":"同源康医药－Ｂ(02410)股价上升5.59%，现价港币$25.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2484172446","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484172446?lang=zh_cn&edition=full","pubTime":"2024-11-18 15:59","pubTimestamp":1731916740,"startTime":"0","endTime":"0","summary":"[上升股]同源康医药－Ｂ(02410) 股价在下午03:59比前收市价上升5.59%，现股价为港币$25.5。至目前为止，今日最高价为$25.5，而最低价为$22.5。总成交量为7.65万股，总成交金额为港币$182.412万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2411182593/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["159938","BK1161","02410","BK1515","BK1574","09939"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.232},{"period":"1month","weight":0.8862},{"period":"3month","weight":0.9159},{"period":"6month","weight":3.5207},{"period":"ytd","weight":3.5207}],"compareEarnings":[{"period":"1week","weight":-0.0125},{"period":"1month","weight":0.0008},{"period":"3month","weight":0.0801},{"period":"6month","weight":0.0939},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1568}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。该公司专注于小分子药物开发，其主要产品包括TY-9591、TY-302和TY-2136。TY-9591是一种第三代EGFR-TKI，对EGFR突变具有抗肿瘤作用。TY-302是一种为治疗乳腺癌及前列腺癌等晚期实体瘤而开发的强效、选择性口服CDK4/6抑制剂。TY-2136b为自主研发、口服ROS1/NTRK抑制剂，用于治疗实体瘤。","exchange":"SEHK","name":"同源康医药-B","nameEN":"TYK MEDICINES-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"同源康医药-B(02410)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供同源康医药-B(02410)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"同源康医药-B,02410,同源康医药-B股票,同源康医药-B股票老虎,同源康医药-B股票老虎国际,同源康医药-B行情,同源康医药-B股票行情,同源康医药-B股价,同源康医药-B股市,同源康医药-B股票价格,同源康医药-B股票交易,同源康医药-B股票购买,同源康医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"同源康医药-B(02410)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供同源康医药-B(02410)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}